Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG)

Centre Hospitalier Universitaire Dijon286 enrolled

Overview

The aim of this study is to determine the prevalence of diabetes and non-diabetic glucose metabolism anomalies (glucose intolerance, non-diabetic fasting hyperglycaemia in patients about to undergo coronary artery bypass grafting (CABG). In addition, the effect of these anomalies on post CABG morbi/mortality in the short term will be evaluated.

Study Type

OBSERVATIONAL

Enrollment

286

Conditions

Anomalies in Glucose Metabolism Coronary Artery Bypass Graft

Interventions

Collection of biological dataOTHER

Collection of clinical dataOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * persons who have provided oral consent * patients about to undergo coronary artery bypass grafting * age \>18 years Exclusion Criteria: * persons without national health insurance cover * Adults under guardianship * Pregnant or breast-feeding women

Locations (1)

CHU Dijon Bourgogne

Dijon, France

Outcomes

Primary Outcomes

Percentage of glucose anomalies (non-diabetic fasting hyperglycaemia, glucose intolerance, diabetes) in CAD patients about to undergo coronary artery bypass grafting.

Time frame: Change from inclusion to week 2 and up to month 3

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.